Experts Clear the Air on the Disease and Treatment Burden of Chronic Rhinosinusitis with Nasal Polyps

For this article, EMJ interviewed Philippe Gevaert, who is a Professor in Rhinology and Allergy at the Department of Otorhinolaryngology in Ghent University, Belgium. Gevaert is a prominent figure in chronic rhinosinusitis and allergic rhinitis, having been involved in the European Rhinologic Society (ERS) and past-Chair of the ear, nose, throat (ENT) section of the European Academy of Allergy and Clinical Immunology (EAACI). In this interview, Gevaert explores the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and shares his expert recommendations on streamlining their recognition and diagnosis, navigating the current unmet needs in patient and clinician education, as well as advocating for strengthened patient support systems. He stresses the importance of healthcare professionals working collaboratively to strategise and exchange best practices. Looking ahead, Gevaert expresses his optimism for the future of care and treatment for patients with CRSwNP.

Publication Details

Journal
EMJ Allergy & Immunology
Published
2025-08-28
DOI
https://doi.org/10.33590/emjallergyimmunol/epwf7628
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Experts Clear the Air on the Disease and Treatment Burden of Chronic Rhinosinusitis with Nasal Polyps

3 links
EMJ Allergy & Immunology
Sinusitis and nasal conditions
article

Experts Clear the Air on the Disease and Treatment Burden of Chronic Rhinosinusitis with Nasal Polyps

article en

Abstract

For this article, EMJ interviewed Philippe Gevaert, who is a Professor in Rhinology and Allergy at the Department of Otorhinolaryngology in Ghent University, Belgium. Gevaert is a prominent figure in chronic rhinosinusitis and allergic rhinitis, having been involved in the European Rhinologic Society (ERS) and past-Chair of the ear, nose, throat (ENT) section of the European Academy of Allergy and Clinical Immunology (EAACI). In this interview, Gevaert explores the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and shares his expert recommendations on streamlining their recognition and diagnosis, navigating the current unmet needs in patient and clinician education, as well as advocating for strengthened patient support systems. He stresses the importance of healthcare professionals working collaboratively to strategise and exchange best practices. Looking ahead, Gevaert expresses his optimism for the future of care and treatment for patients with CRSwNP.

EMJ Allergy & Immunology
AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron Pharmaceuticals, Argenx, Genentech, Sanofi Genzyme
Openalex Percentile: Top 70%
Sinusitis and nasal conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Experts Clear the Air on the Disease and Treatment Burden of Chronic Rhinosinusitis with Nasal Polyps · EMJ Allergy & Immunology (2025) | TGRS Research Map | TGRS